Verition Fund Management
OACCW

Verition Fund Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Verition Fund Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Sell
23,790
-562
-2% -$472 ﹤0.01% 2015
2026
Q1 		$18.3K Hold
24,352
– – ﹤0.01% 2152
2025
Q4 		$17.3K Hold
24,352
– – ﹤0.01% 3427
2025
Q3 		$21.2K Hold
24,352
– – ﹤0.01% 3691
2025
Q2 		$21.3K Sell
24,352
-3,978
-14% -$3.07K ﹤0.01% 3563
2025
Q1 		$21.2K Sell
28,330
-5,720
-17% -$4.35K ﹤0.01% 3239
2024
Q4 		$29.9K Buy
+34,050
New +$22.3K ﹤0.01% 3155

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Verition Fund Management's OACCW Position: Q2 2026 in Review

Verition Fund Management reduced its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 2.3% in Q2 2026, selling an estimated $472 and leaving 23,790 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

Verition Fund Management first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.9K in Q4 2024. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Verition Fund Management held 23,790 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $22.6K as of Q2 2026.
  • Verition Fund Management sold 562 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q2 2026, an estimated $472.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #2015 holding.
  • Verition Fund Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
  • Verition Fund Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $29.9K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.